Adult Stem Cell Company to Begin Clinical Trials for Critical Limb Ischemia
Harvest Technologies has received FDA authorization to commence the first clinical trials with autologous adult stem cells in the treatment of critical limb ischemia.
Harvest Technologies has received FDA authorization to commence the first clinical trials with autologous adult stem cells in the treatment of critical limb ischemia.
Scientists increase the efficacy of mesenchymal stem cells through a process of molecular “supercharging” for the therapeutic regeneration of heart tissue following myocardial infarction.
The renowned adult stem cell expert, Dr. Colin McGuckin of Newcastle, England is permanently relocating his laboratory and staff to France, citing an unjustified bias toward embryonic stem cell research in the UK, to the detriment of adult stem cell work.
A molecular link has been found between specific genes that regulate aging, cancer, and stem cell activity.
Scientists in Melbourne announce the creation of beating heart muscle from human fat.
Scientists report a new and highly efficient, improved procedure for the reprogramming of adult human somatic cells into iPS (induced pluripotent stem) cells.
Toll Free:
1-800-980-STEM (7836)
Outside or Inside US Call:
1-954-358-3382
Toll Free Fax (US Only):
1-866-755-3951
From Outside US Fax:
1-775-887-1194
Copyright 2025, Stem Cell Insitute Panama. All rights reserved.